Entrada Therapeutics (TRDA) Operating Leases (2022 - 2026)
Entrada Therapeutics (TRDA) reported Operating Leases of $44.1 million for Q2 2026, down 10.5% from $49.28 million a year earlier and down 3.0% from the prior quarter.
Powered by 
Analysis
Entrada Therapeutics (TRDA) Operating Leases (2022 - 2026) Analysis & Trends
At the end of FY2025, Entrada Therapeutics posted Operating Leases of $46.79 million, down 9.4% from FY2024.
- Operating Leases has a three-year compound annual growth rate of 38.7% (FY2022 to FY2025).
- By year, Operating Leases came in at $51.65 million in FY2024 (-14.4%), $60.32 million in FY2023 (+244.1%) and $17.53 million in FY2022.
- The Q2 2026 figure ranks as the lowest quarterly Operating Leases since Q1 2023.
- Year over year, Operating Leases has now declined in each of the last nine quarters, with an average decline of 11.7% over the last eight quarters.
- The high point for year-over-year Operating Leases in five years was Q1 2024 (growth of 537.3%); the low point was Q1 2023 (a decline of 61.8%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $45.47 million (Q1 2026), $46.79 million (Q4 2025) and $48.05 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | Entrada Therapeutics | 195.28 Mn | -164.13 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 44.10 Mn |
| Mar 31, 2026 | 45.47 Mn |
| Dec 31, 2025 | 46.79 Mn |
| Sep 30, 2025 | 48.05 Mn |
| Jun 30, 2025 | 49.28 Mn |
| Mar 31, 2025 | 50.49 Mn |
| Dec 31, 2024 | 51.65 Mn |
| Sep 30, 2024 | 53.58 Mn |
| Jun 30, 2024 | 55.88 Mn |
| Mar 31, 2024 | 58.13 Mn |
| Dec 31, 2023 | 60.32 Mn |
| Sep 30, 2023 | 62.43 Mn |
| Jun 30, 2023 | 65.62 Mn |
| Mar 31, 2023 | 9.12 Mn |
| Dec 31, 2022 | 17.53 Mn |
| Sep 30, 2022 | 19.69 Mn |
| Jun 30, 2022 | 21.80 Mn |
| Mar 31, 2022 | 23.89 Mn |
API Access
Entrada Therapeutics Operating Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-leases&ticker=TRDA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-leases", "ticker": "TRDA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-leases&ticker=TRDA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();